journal article·2024-06Open access

HnRNPA2B1 ISGylation Regulates m6A‐Tagged mRNA Selective Export via ALYREF/NXF1 Complex to Foster Breast Cancer Development

Ting Jin, Liping Yang, Chao Chang, Haojun Luo, Rui Wang, Yubi Gan, Yan Sun, Yuetong Guo, Rui Tang, Shanchun Chen, Die Meng, Peijin Dai, Manran Liu

Advanced Science· Volume 11· Issue 24

Abstract

Abstract Regulating nuclear export precisely is essential for maintaining mRNA homeostasis and impacts tumor progression. However, the mechanisms governing nuclear mRNA export remain poorly elucidated. Herein, it is revealed that the enhanced hypoxic long no‐ncoding RNA (lncRNA prostate cancer associated transcript 6 (PCAT6) in breast cancer (BC) promotes the nuclear export of m6A‐modified mRNAs, bolstering breast cancer stem cells (BCSCs) stemness and doxorubicin resistance. Clinically, hypoxic PCAT6 correlates with malignant BC features and poor prognosis. Mechanically, PCAT6 functions as a scaffold between interferon‐stimulated gene 15 (ISG15) and heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1), leading to ISGylation of hnRNPA2B1, thus protecting hnRNPA2B1 from ubiquitination‐mediated proteasomal degradation. Interestingly, as an m6A reader, hnRNPA2B1 selectively mediates m6A‐tagged mRNAs nuclear export via the Aly/REF export factor (ALYREF)/ nuclear RNA export factor 1 (NXF1) complex, which promotes stemness‐related genes expression. HnRNPA2B1 knockdown or mRNA export inhibition can result in the retention of nuclear m6A‐tagged mRNA associated with stemness maintenance, which suppresses BCSCs self‐renewal and effectively improves the efficacy of doxorubicin therapy. These findings demonstrate the pivotal role of m6A‐modified mRNA nuclear export in BC progression, highlighting that the inhibition of m6A‐tagged mRNA and its nuclear export is a potential therapeutic strategy for the amelioration of cancer chemotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA modifications and cancer · RNA Research and Splicing · Cancer-related molecular mechanisms research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education Chongqing Medical University Chongqing 400016 China

Department of Laboratory Medicine the Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 China

Department of Breast and Thyroid Surgery the Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 China

Department of Cell Biology and Medical Genetics, Basic Medical School Chongqing Medical University Chongqing 400016 China

Funding

National Natural Science Foundation of China

References (44)

Show source-provided references
1. 10.3322/caac.2176310.3322/caac.21763 ↗
2. 10.1016/j.semcancer.2021.03.00810.1016/j.semcancer.2021.03.008 ↗
3. 10.1073/pnas.152231711310.1073/pnas.1522317113 ↗
4. 10.1016/j.ccr.2007.07.00610.1016/j.ccr.2007.07.006 ↗
5. 10.15252/embj.202211062010.15252/embj.2022110620 ↗
6. 10.1186/s12943-019-1122-z10.1186/s12943-019-1122-z ↗
7. 10.2147/OTT.S8283510.2147/OTT.S82835 ↗
8. 10.1016/j.cell.2007.04.01910.1016/j.cell.2007.04.019 ↗
9. 10.1038/s41388-020-01638-910.1038/s41388-020-01638-9 ↗
10. 10.1093/nar/gky04610.1093/nar/gky046 ↗
11. 10.1158/0008-5472.CAN-20-227010.1158/0008-5472.CAN-20-2270 ↗
12. 10.1038/s41467-020-16966-310.1038/s41467-020-16966-3 ↗
13. 10.1038/s41467-020-15112-310.1038/s41467-020-15112-3 ↗
14. 10.1186/s12943-018-0820-210.1186/s12943-018-0820-2 ↗
15. 10.1093/nar/gkx60010.1093/nar/gkx600 ↗
16. 10.1016/j.cell.2015.07.05910.1016/j.cell.2015.07.059 ↗
17. 10.1038/nature74610.1038/nature746 ↗
18. 10.3390/cancers1301004210.3390/cancers13010042 ↗
19. 10.1158/0008-5472.CAN-04-362410.1158/0008-5472.CAN-04-3624 ↗
20. 10.1073/pnas.080253310510.1073/pnas.0802533105 ↗
21. 10.1016/j.molmed.2023.03.00510.1016/j.molmed.2023.03.005 ↗
22. 10.3390/ijms2105166010.3390/ijms21051660 ↗
23. 10.1016/j.celrep.2019.06.07210.1016/j.celrep.2019.06.072 ↗
24. 10.7554/eLife.6515010.7554/eLife.65150 ↗
25. 10.1038/s41392-020-00450-x10.1038/s41392-020-00450-x ↗
26. 10.3390/cells1204067410.3390/cells12040674 ↗
27. 10.1016/j.canlet.2018.09.00710.1016/j.canlet.2018.09.007 ↗
28. 10.1016/j.cell.2015.08.01110.1016/j.cell.2015.08.011 ↗
29. 10.3390/ijms2403182810.3390/ijms24031828 ↗
30. 10.1158/0008-5472.CAN-17-175210.1158/0008-5472.CAN-17-1752 ↗
31. 10.1038/nsmb.337110.1038/nsmb.3371 ↗
32. 10.1038/cr.2016.3910.1038/cr.2016.39 ↗
33. 10.1126/science.aav075810.1126/science.aav0758 ↗
34. 10.1093/nar/gks118810.1093/nar/gks1188 ↗
35. 10.1016/j.redox.2022.10231210.1016/j.redox.2022.102312 ↗
36. 10.1038/s12276-022-00767-310.1038/s12276-022-00767-3 ↗
37. 10.1016/j.canlet.2020.08.00110.1016/j.canlet.2020.08.001 ↗
38. 10.1038/s41419-022-05310-w10.1038/s41419-022-05310-w ↗
39. 10.1016/j.molcel.2023.01.00310.1016/j.molcel.2023.01.003 ↗
40. 10.1242/jcs.25944910.1242/jcs.259449 ↗
41. 10.1016/j.stem.2013.10.00810.1016/j.stem.2013.10.008 ↗
42. 10.7554/eLife.3131110.7554/eLife.31311 ↗
43. 10.1093/nar/gky15610.1093/nar/gky156 ↗
44. 10.1093/nar/gkab06510.1093/nar/gkab065 ↗